Literature DB >> 33679428

Pathogenesis of Acute Kidney Injury in Coronavirus Disease 2019.

Jing-Yi Qian1, Bin Wang1, Lin-Li Lv1, Bi-Cheng Liu1.   

Abstract

Since the outbreak of Coronavirus Disease 2019 (COVID-19) in Wuhan, China, in December of 2019, it has rapidly become a global pandemic. Although acute respiratory disorder is the main manifestation of COVID-19, acute kidney injury (AKI) is another important extrapulmonary complication, which has a critical impact on the prognosis and mortality of patients. Current understanding about the exact pathogenesis of AKI in COVID-19 is unclear. Several studies have suggested that intrarenal, pre-renal and post-renal factors mediated collaboratively by direct virus attack, overloaded immune responses, drugs, sepsis, coagulation dysfunction, and underlying diseases may all be involved in the pathogenesis of AKI. This article reviews the current understanding of the pathogenesis of AKI in COVID-19.
Copyright © 2021 Qian, Wang, Lv and Liu.

Entities:  

Keywords:  ACE2; SARS-CoV-2; acute kidney injury; coronavirus disease 2019; mechanism

Year:  2021        PMID: 33679428      PMCID: PMC7928360          DOI: 10.3389/fphys.2021.586589

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  4 in total

1.  Acute Kidney Injury Incidence, Stage, and Recovery in Patients with COVID-19.

Authors:  Lucie Bandelac; Kaanan D Shah; Pravish Purmessur; Haider Ghazanfar; Rabih Nasr
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-03-05

2.  Assessment of Mortality Rate, Need for ICU Admission and Ventilation in COVID-19 Patients with Diabetes Mellitus.

Authors:  Mehrnoosh Zakerkish; Maryam Shaabanpour Fooladi; Hajieh Bibi Shahbazian; Fatemeh Ahmadi; Seyed Peyman Payami; Mehrdad Dargahi-Malamir
Journal:  Qatar Med J       Date:  2022-03-01

3.  Correlations between Kidney and Heart Function Bioindicators and the Expressions of Toll-Like, ACE2, and NRP-1 Receptors in COVID-19.

Authors:  Rabab Hussain Sultan; Basem H Elesawy; Tarek M Ali; Maged Abdallah; Hebatallah Hany Assal; Amr E Ahmed; Osama M Ahmed
Journal:  Vaccines (Basel)       Date:  2022-07-11

4.  [Kidney damage in COVID-19].

Authors:  Stéphane Burtey; Marion Sallée
Journal:  Nephrol Ther       Date:  2021-06-23       Impact factor: 0.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.